- Previous Close
5.50 - Open
5.50 - Bid 5.40 x --
- Ask 5.45 x --
- Day's Range
5.40 - 5.50 - 52 Week Range
5.40 - 6.00 - Volume
388,000 - Avg. Volume
1,446 - Market Cap (intraday)
2.976B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
17.03 - EPS (TTM)
0.32 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 26, 2024
- 1y Target Est
--
Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Ratchaphruek Hospital name in Thailand. The company provides medical services in the field of internal medicine, such as pulmonary, cardiology, dermatology, neurology, hematology, rheumatology, gastroenterology, nephrology, and diabetes and endocrine; general, urological, and colorectal surgeries, as well as men health; and pediatrics, orthopedics, otorhinolaryngology, ophthalmology, obstetrics and gynecology, check-up, dentistry, anesthesiology, emergency medical, stroke, breast, hearing and balance, rehabilitation, and diagnostic radiology. It also sells medicines and medical supplies. The company was formerly known as Sithan Karnpat Company Limited and changed its name to Ratchaphruek Hospital Public Company Limited in September 2016. Ratchaphruek Hospital Public Company Limited was incorporated in 1993 and is based in Khon Kaen, Thailand.
rph.co.th--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RPH-R.BK
View MorePerformance Overview: RPH-R.BK
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RPH-R.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RPH-R.BK
View MoreValuation Measures
Market Cap
3.00B
Enterprise Value
2.59B
Trailing P/E
17.19
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.62
Price/Book (mrq)
1.73
Enterprise Value/Revenue
2.26
Enterprise Value/EBITDA
8.58
Financial Highlights
Profitability and Income Statement
Profit Margin
15.35%
Return on Assets (ttm)
6.71%
Return on Equity (ttm)
10.19%
Revenue (ttm)
1.15B
Net Income Avi to Common (ttm)
176.19M
Diluted EPS (ttm)
0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
386.05M
Total Debt/Equity (mrq)
0.24%
Levered Free Cash Flow (ttm)
234.29M